Supaglutide
A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients(SUPER-1)
Shanghai Yinnuo Pharmaceutical Technology Co. · Phase 2/3 · Completed · Enrollment 547
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Supaglutide RP3D high dose | n/r | n/r | n/r | n/r | n/r |
| supaglutide RD3D Low dose | n/r | n/r | n/r | n/r | n/r |
| placebo | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.